Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-25 @ 3:01 AM
NCT ID:
NCT03116633
Eligibility Criteria:
Inclusion Criteria:
* Written, signed and dated informed consent
* Male \& female patients aged 18 years and over diagnosed with stage IIIb/IV non-squamous NSCLC.
* Patients intended to initiate first-line treatment (Arms A and B)
* Patients who plan to have or have had a recent tumor tissue biopsy taken as part of their standard of care (Arm A)
* Patient must understand and be able, willing and likely to fully comply with all study procedures and restrictions.
Exclusion Criteria:
* Patients who have received any approved or experimental cancer therapy since their most recent NSCLC tissue biopsy
* Any history of metastatic cancer.
* Previous malignancy in the last 2 years (except basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix).
* Patient with a severe acute or chronic medical or psychiatric condition or laboratory abnormality
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03116633
Study Brief:
Protocol Section:
NCT03116633